Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1983 2
1984 3
1985 5
1986 2
1987 2
1988 4
1990 2
1991 4
1992 1
1993 4
1994 5
1995 2
1996 3
1997 8
1998 3
1999 4
2000 5
2001 6
2002 2
2003 7
2004 3
2005 2
2006 3
2007 1
2008 1
2009 1
2010 8
2011 7
2012 10
2013 8
2014 8
2015 11
2016 9
2017 16
2018 17
2019 20
2020 13
2021 15
2022 10
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.
Paiva B, Puig N, Cedena MT, Rosiñol L, Cordón L, Vidriales MB, Burgos L, Flores-Montero J, Sanoja-Flores L, Lopez-Anglada L, Maldonado R, de la Cruz J, Gutierrez NC, Calasanz MJ, Martin-Ramos ML, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios R, Martin J, Martinez-Martinez R, Sureda A, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Van Dongen JJM, Orfao A, Mateos MV, Blade J, San-Miguel JF, Lahuerta JJ; GEM (Grupo Español de Mieloma)/PETHEMA (Programa Para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group. Paiva B, et al. Among authors: moraleda jm. J Clin Oncol. 2020 Mar 10;38(8):784-792. doi: 10.1200/JCO.19.01231. Epub 2019 Nov 26. J Clin Oncol. 2020. PMID: 31770060 Free article.
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.
Rosiñol L, Oriol A, Rios R, Sureda A, Blanchard MJ, Hernández MT, Martínez-Martínez R, Moraleda JM, Jarque I, Bargay J, Gironella M, de Arriba F, Palomera L, González-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, González AP, Casado LF, López-Anglada L, Paiva B, Mateos MV, San Miguel JF, Lahuerta JJ, Bladé J. Rosiñol L, et al. Among authors: moraleda jm. Blood. 2019 Oct 17;134(16):1337-1345. doi: 10.1182/blood.2019000241. Blood. 2019. PMID: 31484647 Free PMC article. Clinical Trial.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Oliver-Caldés A, González-Calle V, Cabañas V, Español-Rego M, Rodríguez-Otero P, Reguera JL, López-Corral L, Martin-Antonio B, Zabaleta A, Inogés S, Varea S, Rosiñol L, López-Díaz de Cerio A, Tovar N, Jiménez R, López-Parra M, Rodríguez-Lobato LG, Sánchez-Salinas A, Olesti E, Calvo-Orteu M, Delgado J, Pérez-Simón JA, Paiva B, Prósper F, Sáez-Peñataro J, Juan M, Moraleda JM, Mateos MV, Pascal M, Urbano-Ispizua A, Fernández de Larrea C. Oliver-Caldés A, et al. Among authors: moraleda jm. Lancet Oncol. 2023 Aug;24(8):913-924. doi: 10.1016/S1470-2045(23)00222-X. Epub 2023 Jul 3. Lancet Oncol. 2023. PMID: 37414060
New Insights Into Pathophysiology of β-Thalassemia.
Sanchez-Villalobos M, Blanquer M, Moraleda JM, Salido EJ, Perez-Oliva AB. Sanchez-Villalobos M, et al. Among authors: moraleda jm. Front Med (Lausanne). 2022 Apr 12;9:880752. doi: 10.3389/fmed.2022.880752. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492364 Free PMC article.
Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia.
Serrano C, Español I, Cascales A, Moraleda JM. Serrano C, et al. Among authors: moraleda jm. SN Compr Clin Med. 2021;3(12):2389-2392. doi: 10.1007/s42399-021-01019-7. Epub 2021 Jul 20. SN Compr Clin Med. 2021. PMID: 34308259 Free PMC article. No abstract available.
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.
Fernández-Santos ME, Garcia-Arranz M, Andreu EJ, García-Hernández AM, López-Parra M, Villarón E, Sepúlveda P, Fernández-Avilés F, García-Olmo D, Prosper F, Sánchez-Guijo F, Moraleda JM, Zapata AG. Fernández-Santos ME, et al. Among authors: moraleda jm. Front Immunol. 2022 Jun 9;13:918565. doi: 10.3389/fimmu.2022.918565. eCollection 2022. Front Immunol. 2022. PMID: 35812460 Free PMC article. Review.
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.
Richardson E, García-Bernal D, Calabretta E, Jara R, Palomo M, Baron RM, Yanik G, Fareed J, Vlodavsky I, Iacobelli M, Díaz-Ricart M, Richardson PG, Carlo-Stella C, Moraleda JM. Richardson E, et al. Among authors: moraleda jm. Expert Opin Ther Targets. 2021 Jun;25(6):423-433. doi: 10.1080/14728222.2021.1944101. Epub 2021 Jun 25. Expert Opin Ther Targets. 2021. PMID: 34167431 Review.
Mesenchymal dental stem cells in regenerative dentistry.
Rodríguez-Lozano FJ, Insausti CL, Iniesta F, Blanquer M, Ramírez MD, Meseguer L, Meseguer-Henarejos AB, Marín N, Martínez S, Moraleda JM. Rodríguez-Lozano FJ, et al. Among authors: moraleda jm. Med Oral Patol Oral Cir Bucal. 2012 Nov 1;17(6):e1062-7. doi: 10.4317/medoral.17925. Med Oral Patol Oral Cir Bucal. 2012. PMID: 22926467 Free PMC article. Review.
224 results